AOL Web Search

Novavax’s shot would be the fourth Covid vaccine authorized for use in the U.S. and the first new one since the Johnson & Johnson vaccine was cleared in February 2021. Novavax was one of the early...

The Novavax vaccine, in development since early 2020, was first authorized for emergency use in Indonesia in November 2021. It has since been authorized in the Philippines, India, the European...

Novavax will be the first protein-based vaccine for COVID-19 available in the US, though the technology has been around for decades. While this type of vaccine has some advantages in the pandemic,...

Last May, Novavax told investors it expected to file for the FDA's authorization "in the third quarter of 2021." Over the summer, the company disclosed the Biden administration had paused funding...

HHS said in a statement on Monday that it is coordinating with Novavax "to receive a limited quantity of vaccine and will make that vaccine available to the American public" once those steps are...

The U.S. Food and Drug Administration is currently considering granting emergency use authorization to the Novavax COVID-19 vaccine. The Supreme Court is considering a religious exemption case As the current Supreme Court term winds town, court watchers are waiting to see whether the justices will take up Dr. A v.

Novavax launched a phase 1/2 study of its candidate back in September. The investigational vaccine includes Novavax's coronavirus vaccine and its flu vaccine candidate, NanoFlu. Prior to the...

The Novavax vaccine did elicit immune responses to the omicron variant, but it provided less protection compared to the initial Wuhan strain and the other variants, as we’ve seen with all of the currently available COVID-19 vaccines. Studies also looked at responses after a booster dose, provided in this phase 3 study.